EUVIMEDEUVIMED entdecken
Crossref

Near complete responses to concurrent brentuximab vedotin and ultra-hypofractionated low-dose total skin electron beam radiation in advanced cutaneous T-cell lymphoma

Mathias Oymanns iD, Michael Daum-Marzian, Aliyah Bellm, Khaled Elsayad, Hans T Eich, Chalid Assaf

British Journal of Dermatology · 23.01.2023 · 188 (1) · 145-146

DOI: 10.1093/bjd/ljac012 ↗

Kurz gefasst

Fachartikel in der Zeitschrift British Journal of Dermatology, online erschienen am 20.10.2022. Verfasst von Mathias Oymanns und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology and Venerology, Helios Klinikum Krefeld, Krefeld, Germany. Hauptthemen laut MEDLINE: Immunoconjugates, Lymphoma, T-Cell, Cutaneous, Skin Neoplasms. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 8 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Patients with advanced stage mycosis fungoides (MF) or Sézary syndrome (SS) have a poor prognosis. Despite many available active single agents for CTCL treatment, high remission rates and long-lasting responses are rarely achieved in advanced CTCL [1]. Therefore, it is important to find more effective strategies, e.g. combination therapy, which could enhance efficacy by targeting key pathways in a synergistic or additive manner. We report on three patients with tumor stage MF (IIB) with fast response and very good partial remission due to induction with BV with 1.8 mg/kg dose concurrently in combination with ultra-hypofractionated low dose TSEBT.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ImmunoconjugatesLymphoma, T-Cell, CutaneousSkin NeoplasmsHumansBrentuximab VedotinElectronsKi-1 Antigen

Substanzen

Brentuximab VedotinImmunoconjugatesKi-1 Antigen

Autor:innen und Institutionen

  • Department of Dermatology and Venerology, Helios Klinikum Krefeld, Krefeld, Germany.
  • Department of Radiotherapy and Radiooncology, Helios Klinikum Krefeld, Krefeld, Germany.
  • Department of Pediatrics, HELIOS Klinikum Krefeld, Krefeld, Germany.
  • Department of Radiation Therapy and Radio-Oncology, University Hospital Münster, Münster, Germany.
  • Institute for Molecular Medicine, Medical School Hamburg, Hamburg, Germany.

ORCID-Profile: Mathias Oymanns

Zitieren

APA

Oymanns, M., Daum-Marzian, M., Bellm, A., Elsayad, K., Eich, H. T., & Assaf, C. (2023). Near complete responses to concurrent brentuximab vedotin and ultra-hypofractionated low-dose total skin electron beam radiation in advanced cutaneous T-cell lymphoma. British Journal of Dermatology, 188(1), 145-146. https://doi.org/10.1093/bjd/ljac012

Vancouver

Oymanns M, Daum-Marzian M, Bellm A, Elsayad K, Eich HT, Assaf C. Near complete responses to concurrent brentuximab vedotin and ultra-hypofractionated low-dose total skin electron beam radiation in advanced cutaneous T-cell lymphoma. British Journal of Dermatology. 2023;188(1):145-146. doi:10.1093/bjd/ljac012

BibTeX
@article{Oymanns2023,
  author = {Oymanns, Mathias and Daum-Marzian, Michael and Bellm, Aliyah and Elsayad, Khaled and Eich, Hans T and Assaf, Chalid},
  title = {Near complete responses to concurrent brentuximab vedotin and ultra-hypofractionated low-dose total skin electron beam radiation in advanced cutaneous T-cell lymphoma},
  journal = {British Journal of Dermatology},
  year = {2023},
  volume = {188},
  number = {1},
  pages = {145--146},
  doi = {10.1093/bjd/ljac012}
}
Kostenlos starten →